Addex Therapeutics (ADXN) announced that following the previously announced termination of development of ADX71149 in epilepsy, its partner ...

DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...

Shannon Storms Beador has so much gratitude for her life with her three daughters and dog, Archie. Get the details here.

TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension inadequately controlled by existing treatments. TRYVIO ...